Jump to content


The case for ponatinib

  • Please log in to reply
No replies to this topic

#1 chriskuo


    Advanced Member

  • Members
  • PipPipPip
  • 367 posts

Posted 29 August 2012 - 06:15 PM

This article is focused on the business case for ponatinib but it does include some

interesting data and charts on its efficacy.


1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users